致癌物
入射(几何)
生物测定
医学
毒理
病理
生理学
最大耐受剂量
癌变
毒性
流行病学
内科学
相似性(几何)
药理学
肿瘤科
癌症
肿瘤细胞
作者
Madhav G. Paranjpe,Amod Kale,Narendra Deshmukh,C.C. Magar,Prashant Nalge,Devendra D. Patel
标识
DOI:10.1177/10915818251380554
摘要
The Tg.rasH2 mouse is a validated bioassay system for evaluation of carcinogenic potential, and it is confirmed to be sensitive to both genotoxic and nongenotoxic carcinogens. This is also one of the models specified in ICH S1B Guidance, enabling 6-month carcinogenicity studies as an alternative to traditional 2-year bioassays. We conducted a 26-week carcinogenicity study at our test facility on Tg.rasH2 mice sourced from CLEA Japan Inc., in a process to generate historical control database. Although historical control data have been published for these mice sourced from Taconic Biosciences Inc., USA, there is a dearth of published literature citing spontaneous incidence of neoplastic findings in Tg.rasH2 mice sourced from CLEA Japan. We have therefore presented the spontaneous tumor incidence in our study and compared it with the previously published tumor incidence for Tg.rasH2 mice sourced from Taconic, USA. The comparison reveals a similarity of tumor incidence between the mice from these two sources.
科研通智能强力驱动
Strongly Powered by AbleSci AI